Following are the stocks where profit booking is seen taking place in the F&O segment.

The lending business continued to show very strong growth as a result of the rapid scale-up of all of company’s lending products, including postpaid, consumer loans, and merchant loans.

The company has always maintained that the mobile average revenue per user (ARPU) needs to be at Rs 200 and ultimately at Rs 300, so as to provide a reasonable return on capital that allows for a financially healthy business model.   

Several IT stocks were seen outperforming the markets in the week gone by with few of them gaining up to 34 per cent in one week alone.

 Several mid cap stocks however were seen outperforming the markets in the past one week.

Several small cap stocks were seen outperforming the markets in the past one week with few gaining by more than 10 per cent each in the similar period.

While there was weakness in the market, several textile stocks were seen outperforming the benchmark indices. Some of the textile companies were seen gaining by more than 46 per cent in one week alone.

On a weekly basis the stock has plunged 4.62 per cent. The level of Rs 2450 is an important support level for the stock.

Interestingly, the stock formed an inside bar on the weekly chart with open=low; hence, the high and low remains a crucial level for the stock in the near term. Meanwhile, the stock is seen trading below its 50-week EMA and also, below the 61.8 per cent retracement level.   

Biocon Biologics Ltd, a subsidiary of Biocon Ltd, and Viatris Inc confirm that Insulin Glargine injection will be offered through the Walgreens Prescription Savings Club, saving members up to 80 per cent off the cash price of comparable long-acting insulins purchased at Walgreens.